Nevertheless, technical advances at lower field strengths -like acceleration techniques or new AI applications that can synthesize equally high-resolution, high contrast-to-noise ratio (CNR) images from lower field data -have started to make clinically more accepted lower field strengths serious competitors regarding image detail and speed. However, another advantage of UHF MRI that cannot be readily achieved at lower field strengths is its increased spectral resolution and consequent increased sensitivity to (macro)molecules and nuclei other than protons (x-nuclei) that could be of clinical interest. For instance, magnetization transfer techniques at UHF provide more detailed information on different metabolites, which can be utilized to for instance probe the structure of myelin, an essential element in the transport of nerve impulses. Another example is MR spectroscopy, which seems to have never really achieved its full potential in the clinic, not in the least due to overlapping metabolites hampering true tissue probing. UHF MRI therefore could give us access not only to anatomy with a precision that is not readily accessible on standard clinical devices, but also to metabolism, ionic homeostasis, and energetic processes in vivo within the human body with an unmatched quality. In addition, its non-invasive character allows repeated measurements and thus the generation of kinetic profiles, opening up the possibility of producing biometabolic models that no longer systematically use animal models. Thus, UHF imaging allows to move from an anatomical representation to a dynamic metabolic representation.The articles in this Research Topic provide just a glimpse of the full potential of UHF MRI to visualize metabolites and metabolic pathways, using either proton or x-nuclei imaging. Although the latter necessitates new hardware to be developed, the UHF community has ample experience in this field, as shown in the article by Forner et al. who used specially designed coils for phosphorus spectroscopy exploration of tongue tumors. Phosphorus imaging is also used by Korzovski et al., who show the improvement of regional glioma mapping using 31 P MRS. High spatial resolution sampling allows a better characterization of intra-and peritumoral tissue heterogeneity. This possibility to obtain, without sampling or biopsy, metabolic or genetic information predictive of clinical outcome defines a personalized follow-up in line with 5Ps medicine. Jumping from one x-nucleus to another, Stobbe et al. shows the possibility of identifying and quantifying an alteration of the intra-extracellular sodium compartmentalization in relation to Multiple Sclerosis. Grimaldi et al. even identified new biomarkers using sodium MRI and thus envisaged new pathophysiological approaches in idiopathic Parkinson's disease, by showing an abnormal sodium accumulation within dopaminergic neurons.It is not only x-nuclei imaging where UHF MRI excels compared to lower field strengths. Quantification -instead of using ratios -of neurotransmitters is now a possibility, for instance glutamate which is studied in two studies presented in this Research Topic. O'Grady et al. uses a CEST sequence to measure glutamate in MS patients, finding a correlation between glutamate in certain regions and disability and cognitive function, while Park et al. developed a protocol for glutamate and GABA measurements that can be used for probing the changes of these neurotransmitters under different conditions, like hyperglycemia. Finally, Shams et al. shows the potential of UHF metabolic MRI to extract genomic information in vivo, by detecting 2OH Glutarate (2HG), a metabolic correlate of the IDH mutation quantified in a much more reliable manner than at 3T. By in vivo functional and metabolic sampling of the brain, UHF paves the way to in vivo characterization of genomic mutations by means of their metabolic counterparts. Combining this with AI-driven quantitative analysis of the data could ultimately lead to the development of a 'digital twin': rebuilding a lesion within the organ, allowing virtual biopsy as well as therapeutic simulation (e.g., neurosurgical procedures) and treatment monitoring, all in a noninvasive way.
7 Authors
- SG
Stephan Grimaldi
APHM, Hôpital Universitaire Timone, Department of Neurology and Movement Disorders, France
- MM
Mohamed Mounir El Mendili
APHM, Hôpital Universitaire Timone, CEMEREM, France
- WZ
Wafaa Zaaraoui
APHM, Hôpital Universitaire Timone, CEMEREM, France
- JR
Jean-Philippe Ranjeva
APHM, Hôpital Universitaire Timone, CEMEREM, France
- JA
Jean-Philippe Azulay
APHM, Hôpital Universitaire Timone, Department of Neurology and Movement Disorders, France
- AE
Alexandre Eusebio
APHM, Hôpital Universitaire Timone, Department of Neurology and Movement Disorders, France
- MG
Maxime Guye
APHM, Hôpital Universitaire Timone, CEMEREM, France
9 Authors
- ZS
Zahra Shams
Department of Radiology, University Medical Center Utrecht, Netherlands
- WJ
Wybe J. M. van der Kemp
Department of Radiology, University Medical Center Utrecht, Netherlands
- UE
Uzay Emir
School of Health Sciences, Purdue University, United States
- JW
Jan Willem Dankbaar
Department of Radiology, University Medical Center Utrecht, Netherlands
- TJ
Tom J. Snijders
Department of Neurology & Neurosurgery, University Medical Center Utrecht/UMC Utrecht Brain Center, Netherlands
- FY
Filip Y. F. de Vos
Department of Medical Oncology, University Medical Center Utrecht, Netherlands
- DW
Dennis W. J. Klomp
Department of Radiology, University Medical Center Utrecht, Netherlands
- JP
Jannie P. Wijnen
Department of Radiology, University Medical Center Utrecht, Netherlands
- EC
Evita C. Wiegers
Department of Radiology, University Medical Center Utrecht, Netherlands
8 Authors
- YW
Young Woo Park
Department of Radiology, Center for Magnetic Resonance Research, University of Minnesota, United States
- DK
Dinesh K. Deelchand
Department of Radiology, Center for Magnetic Resonance Research, University of Minnesota, United States
- JM
James M. Joers
Department of Radiology, Center for Magnetic Resonance Research, University of Minnesota, United States
- AK
Anjali Kumar
Department of Medicine, University of Minnesota, United States
- AB
Alison Bunio Alvear
Department of Medicine, University of Minnesota, United States
- AM
Amir Moheet
Department of Medicine, University of Minnesota, United States
- ER
Elizabeth R. Seaquist
Department of Medicine, University of Minnesota, United States
- GÖ
Gülin Öz
Department of Radiology, Center for Magnetic Resonance Research, University of Minnesota, United States
3,407 views
12 citations



